在尼日尔减少儿童死亡率的阿齐思罗米大规模药物管理 (AVENIR II):一个集群随机化适应性平台试验的总协议,以评估基于社区的卫生干预措施
Ahmed M Arzika1, Abdou Amza2, Sani Ousmane3
1Centre de Recherche et Interventions en Santé Publique, Birni N'Gaoure, Niger.
Trials
|February 19, 2026
概括
在儿童中,大规模的阿齐思罗米药物管理 (MDA) 降低了死亡率,但增加了抗菌素耐药性 (AMR). 尼日尔的这种适应性平台试验可以监测这些影响,同时可以灵活评估社区卫生干预措施.
科学领域:
- 全球健康 全球健康
- 传染病流行病学 传染病流行病学
- 临床试验设计 临床试验设计
背景情况:
- 在1-59个月的儿童中,大规模的阿兹罗米辛药物管理 (MDA) 降低了死亡率,但引起了对抗菌素耐药性 (AMR) 的担忧.
- 世界卫生组织建议在MDA计划中同时监测死亡率和AMR.
- 尼日尔正在扩大其针对儿童生存的全国性阿齐思罗米辛MDA计划.
研究的目的:
- 为尼日尔不断扩大的阿兹胺MDA倡议建立强有力的计划监测.
- 评估阿齐思罗米MDA对5岁以下死亡率和AMR的影响.
- 创建一个灵活的平台,与MDA一起评估其他社区卫生干预措施.
主要方法:
- 一个集群随机化的自适应平台试验设计 (AVENIR II),每两年重新随机化一次.
- 监测5岁以下的死亡率,AMR,实施和安全结果.
- 适应性算法以平衡程序交付与AMR监测,随机化子集来延迟或停止MDA.
主要成果:
- 该研究旨在两年间监测死亡率和抗药性耐药性,并持续执行/安全.
- 一个自适应算法将指导随机化比例延迟或停止MDA.
- 该平台允许添加或删除研究臂和评估额外的干预措施.
结论:
- 艾维尼尔II试验解决了对阿兹罗米辛MDA的AMR的担忧.
- 它为严格,持续评估计划影响和未来干预措施的灵活性提供了一个框架.
- 这种设计支持尼日尔及其他地区的公共卫生计划的基于证据的决策.
相关概念视频
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
289
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
289
01:29Drug Dosing: Infants and Children
344
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
344
01:26Methods Of Healthcare Delivery System
4.2K
At the different levels of the healthcare system, we see varying methods of healthcare used. These methods include managed care systems, case management, and primary healthcare.
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
4.2K
01:28Dosage Regimens: Designs and Approaches
350
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
350
01:15Drug Dosage Regimen: Overview
4.5K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
4.5K
01:21Intrauterine Drug Delivery Systems
33
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
33